Handelsbanken Fonder
KURA icon

Handelsbanken Fonder’s Kura Oncology KURA Stock Holding History

Handelsbanken Fonder’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,800
Closed -$238K – 1659
2022
Q1 		$238K Hold
14,800
– – ﹤0.01% 1595
2021
Q4 		$207K Hold
14,800
– – ﹤0.01% 1700
2021
Q3 		$277K Hold
14,800
– – ﹤0.01% 1605
2021
Q2 		$309K Buy
14,800
+1,800
+14% +$44.7K ﹤0.01% 1624
2021
Q1 		$368K Buy
+13,000
New +$411K ﹤0.01% 1355

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Handelsbanken Fonder's KURA Position: Q2 2022 in Review

Handelsbanken Fonder sold out of Kura Oncology (KURA) in Q2 2022, closing a stake of 14,800 shares — an estimated $238K sold.

Handelsbanken Fonder first reported a position in KURA in Q1 2021 and held it in 5 quarters. The position peaked at $368K in Q1 2021. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2022.

  • Handelsbanken Fonder reported no remaining Kura Oncology position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 14,800 Kura Oncology shares in Q2 2022, an estimated $238K.
  • Handelsbanken Fonder first reported a position in Kura Oncology in Q1 2021 and held it in 5 quarters.
  • Handelsbanken Fonder's Kura Oncology position peaked at $368K in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.